Cargando…

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents

Detalles Bibliográficos
Autores principales:	Ladin, Daniel A., Soliman, Eman, Griffin, LaToya, Van Dross, Rukiyah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322943/ https://www.ncbi.nlm.nih.gov/pubmed/34335283 http://dx.doi.org/10.3389/fphar.2021.732903

Ejemplares similares

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2016)

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
por: Soderstrom, Ken, et al.
Publicado: (2017)

Apoptosis mechanisms induced by 15d-PMJ(2) in HCT116 colon cancer cells: insights into CHOP10/TRB3/Akt signaling
por: Albassam, Hussam, et al.
Publicado: (2023)

Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ(12,14) prostamide J(2)
por: Elhassanny, Ahmed, et al.
Publicado: (2020)

Kinin B1R Activation Induces Endoplasmic Reticulum Stress in Primary Hypothalamic Neurons
por: White, Acacia, et al.
Publicado: (2022)

Calcium signaling induced by 15-deoxy-prostamide-J(2) promotes cell death by activating PERK, IP3R, and the mitochondrial permeability transition pore
por: Ladin, Daniel A., et al.
Publicado: (2022)

Corrigendum: Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
por: Choudhari, Amit S., et al.
Publicado: (2020)

Heme-Dependent ER Stress Apoptosis: A Mechanism for the Selective Toxicity of the Dihydroartemisinin, NSC735847, in Colorectal Cancer Cells
por: Elhassanny, Ahmed E. M., et al.
Publicado: (2020)

Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model
por: Griffin, Aliesha, et al.
Publicado: (2020)

The discovery of rivaroxaban: translating preclinical assessments into clinical practice
por: Kubitza, Dagmar, et al.
Publicado: (2013)

Anti-Allergic Properties of Propolis: Evidence From Preclinical and Clinical Studies
por: Liew, Kong Yen, et al.
Publicado: (2022)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
por: Aso, Ester, et al.
Publicado: (2014)

Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells
por: Yüksel, Büşra, et al.
Publicado: (2023)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Emerging Role of (Endo)Cannabinoids in Migraine
por: Leimuranta, Pinja, et al.
Publicado: (2018)

Antitumor Cannabinoid Chemotypes: Structural Insights
por: Morales, Paula, et al.
Publicado: (2019)

Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022)

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
por: Zagzoog, Ayat, et al.
Publicado: (2022)

Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice
por: Chen, Wei, et al.
Publicado: (2017)

It Takes ALL of US:: Promoting Preconception Health in Delaware
por: Brathwaite, LaToya
Publicado: (2022)

Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
por: Colvin, Emily K., et al.
Publicado: (2022)

Corrigendum: Assessment of the anti-inflammatory, antibacterial and anti-aging properties and possible use on the skin of hydrogels containing Epilobium angustifolium L. extracts
por: Nowak, Anna, et al.
Publicado: (2022)

Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent
por: Tian, Xin, et al.
Publicado: (2016)

Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
por: Liu, Qing-Rong, et al.
Publicado: (2022)

Predicting Approximate Clinically Effective Doses in Oncology Using Preclinical Efficacy and Body Surface Area Conversion: A Retrospective Analysis
por: Griffin, Robert J., et al.
Publicado: (2022)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017)

Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
por: Fisher, Amy S., et al.
Publicado: (2021)

Corrigendum: Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets
por: Lei, Zhixin, et al.
Publicado: (2018)

Targeting the endogenous cannabinoid system to treat neuropathic pain
por: Lau, Benjamin K., et al.
Publicado: (2014)

Cannabinoids and Pain: New Insights From Old Molecules
por: Vučković, Sonja, et al.
Publicado: (2018)

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
por: Rock, Erin M., et al.
Publicado: (2016)

New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling
por: Riquelme-Sandoval, Agustín, et al.
Publicado: (2020)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

Power and the paywall: A Black feminist reflection on the socio-spatial formations of publishing
por: Eaves, LaToya E.
Publicado: (2021)

A protocol for the systematic review and meta-analysis of studies in which cannabinoids were tested for antinociceptive effects in animal models of pathological or injury-related persistent pain
por: Soliman, Nadia, et al.
Publicado: (2019)

Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening
por: Griffin, Aliesha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sn8haoibro437tqao51vjldqdk